In addition to DHFR in microbial pathogens, the enzyme is also targeted in cancer therapy, and methotrexate (MTX), a DHFR inhibitor, is commonly used to inhibit the growth of rapidly dividing cancer cells. Here, DHFR is linked to cancer.